ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs MXN
16.6086
0.00%
Brent Oil
83.76
0.00%
Bitcoin
66,936.66
-0.21%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Eiger BioPharmaceuticals Inc (EIGR)

  7. Eiger BioPharmaceuticals Inc (EIGR) Noticias

EIGR

Eiger BioPharmaceuticals (EIGR)

Eiger BioPharmaceuticals Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:EIGR
FechaHoraFuenteTítuloSímboloCompañía
01/04/202410:12GlobeNewswire Inc.Eiger BioPharmaceuticals Files for Voluntary Chapter 11 ProtectionNASDAQ:EIGREiger BioPharmaceuticals Inc
11/03/202415:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EIGREiger BioPharmaceuticals Inc
18/01/202416:49PR Newswire (US)Eiger and Partner, AnGes, Receive Approval for Zokinvy® (lonafarnib) for Hutchinson- Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies in JapanNASDAQ:EIGREiger BioPharmaceuticals Inc
04/01/202407:00PR Newswire (US)Eiger BioPharmaceuticals, Inc. Announces 1-for-30 Reverse Stock SplitNASDAQ:EIGREiger BioPharmaceuticals Inc
11/12/202315:01Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:EIGREiger BioPharmaceuticals Inc
04/12/202305:01Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:EIGREiger BioPharmaceuticals Inc
01/12/202315:02Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:EIGREiger BioPharmaceuticals Inc
24/11/202305:01Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:EIGREiger BioPharmaceuticals Inc
09/11/202315:27Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EIGREiger BioPharmaceuticals Inc
09/11/202315:05PR Newswire (US)Eiger BioPharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:EIGREiger BioPharmaceuticals Inc
02/11/202320:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EIGREiger BioPharmaceuticals Inc
30/10/202315:51Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:EIGREiger BioPharmaceuticals Inc
28/09/202315:54Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:EIGREiger BioPharmaceuticals Inc
12/09/202316:17Dow Jones NewsEiger BioPharmaceuticals to Discontinue Chronic Hepatitis Delta Study, Ends Licensing TalksNASDAQ:EIGREiger BioPharmaceuticals Inc
12/09/202315:05PR Newswire (US)Eiger to Discontinue Phase 3 LIMT-2 Trial of Peginterferon Lambda in Patients with Chronic Hepatitis DeltaNASDAQ:EIGREiger BioPharmaceuticals Inc
05/09/202315:05PR Newswire (US)Eiger BioPharmaceuticals to Present at H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:EIGREiger BioPharmaceuticals Inc
15/08/202305:00Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:EIGREiger BioPharmaceuticals Inc
14/08/202315:05PR Newswire (US)Eiger BioPharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:EIGREiger BioPharmaceuticals Inc
29/06/202307:00PR Newswire (US)Eiger BioPharmaceuticals to Focus on Metabolic Diseases with Avexitide; David Apelian Takes Helm as CEONASDAQ:EIGREiger BioPharmaceuticals Inc
28/06/202315:05PR Newswire (US)Eiger BioPharmaceuticals to Host Business Update Call TomorrowNASDAQ:EIGREiger BioPharmaceuticals Inc
20/06/202305:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EIGREiger BioPharmaceuticals Inc
11/05/202315:17Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:EIGREiger BioPharmaceuticals Inc
11/05/202315:00PR Newswire (US)Eiger BioPharmaceuticals Reports First Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:EIGREiger BioPharmaceuticals Inc
03/05/202315:05PR Newswire (US)Eiger BioPharmaceuticals Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:EIGREiger BioPharmaceuticals Inc
26/04/202315:40Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:EIGREiger BioPharmaceuticals Inc
26/04/202315:39Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:EIGREiger BioPharmaceuticals Inc
26/04/202315:38Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:EIGREiger BioPharmaceuticals Inc
13/04/202307:00PR Newswire (US)Eiger BioPharmaceuticals Strengthens Management Team with New AppointmentsNASDAQ:EIGREiger BioPharmaceuticals Inc
10/04/202312:38Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:EIGREiger BioPharmaceuticals Inc
17/03/202315:12Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:EIGREiger BioPharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:EIGR

Su Consulta Reciente

COIN
ZCNCGBP
BIT
F15593
Vontobel Financial Produ...
LSE
99KS
Plcs Ppl Hm 28
COIN
DPBTC
COIN
ARAEUR
USOTC
BZLFF
Bunzl (PK)
EU
IYODA
HANETF YODA INAV
COIN
RNDRUSD
Render Token
EU
IFGBL
First FGBL iNav
UNSW
FINETH
DeFiner
TSXV
NEE
Northern Vertex Mining
NASDAQ
DXR
Daxor
NYSE
WBS
Webster Financial
KOSPI
011170
Lotte Chemical
TSXV
AGLD
Austral Gold
TG
66T
Scatec ASA
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados